That's a very very good point you raise there GMFJ.
IMO (and I know this might sound like wanting the cake and eating it), but I would think that if Stimuvax is successful then it likely means CVAC will be too (but perhaps more so due to it being more personalized vaccine) but if Stimuvax is not successful, then CVAC still has a fighting chance to be successful (again due to it being a personalized vaccine).
That may not sound very scientific or very objective, but there could be some truth in it.
Interested to hear other opinions.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $350.4M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $196.2K | 810.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 260204 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 132678 | 2 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |